BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29106817)

  • 1. APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS.
    Nieto-Martínez R; González-Rivas JP; Ugel E; Brajkovich I; Risquez A; Garvey WT; Mechanick JI
    Endocr Pract; 2018 Jan; 24(1):6-13. PubMed ID: 29106817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
    Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
    Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.
    Guo F; Moellering DR; Garvey WT
    Obesity (Silver Spring); 2014 Jan; 22(1):110-8. PubMed ID: 23894121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of body mass index and its long-term changes with cardiometabolic diseases: A nationwide twin study.
    Guo J; Li X; Yang R; Marseglia A; Dove A; Johnell K; Xu W
    Clin Nutr; 2021 Nov; 40(11):5467-5474. PubMed ID: 34656027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
    Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
    Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.
    Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
    Endocr Pract; 2016 Jul; 22(7):842-84. PubMed ID: 27472012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS -
    Mechanick JI; Apovian C; Brethauer S; Garvey WT; Joffe AM; Kim J; Kushner RF; Lindquist R; Pessah-Pollack R; Seger J; Urman RD; Adams S; Cleek JB; Correa R; Figaro MK; Flanders K; Grams J; Hurley DL; Kothari S; Seger MV; Still CD
    Endocr Pract; 2019 Dec; 25(12):1346-1359. PubMed ID: 31682518
    [No Abstract]   [Full Text] [Related]  

  • 11. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
    Pinhas-Hamiel O; Livne M; Harari G; Achiron A
    Eur J Neurol; 2015 Sep; 22(9):1275-9. PubMed ID: 25973530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change in the prevalence of obesity phenotypes and cardiometabolic disorders among children aged 6- 17 in Beijing during 2004- 2013].
    Yan Y; Cheng H; Zhao X; Liu J; Hou D; Su Z; Huang G; Ding W; Liu Q; Mi J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jan; 50(1):34-9. PubMed ID: 26792501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT.
    Mechanick JI; Hurley DL; Garvey WT
    Endocr Pract; 2017 Mar; 23(3):372-378. PubMed ID: 27967229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study.
    Ferrara LA; Capaldo B; Mancusi C; Lee ET; Howard BV; Devereux RB; de Simone G
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):271-6. PubMed ID: 24360764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of neck circumference with body composition and cardiometabolic risk factors in Arab women.
    Albassam RS; Lei KY; Alnaami AM; Al-Daghri NM
    Eat Weight Disord; 2019 Dec; 24(6):1121-1130. PubMed ID: 30603928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.
    Lim SC; Tai ES; Tan BY; Chew SK; Tan CE
    Diabetes Care; 2000 Mar; 23(3):278-82. PubMed ID: 10868851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.